RAPID Assay
diagnostic assay
implementation of RAPID
diagnostic trials
diagnostic test
molecular assay
Rapid Antimicrobial susceptibility testing
surveillance of multi-drug resistance
cost-effective diagnostic tool
exploitative innovation activities RAPID
measures of diagnostic accuracy
molecular resistance markers
resistance profiling
phylogenetic Identification Emerging resistance
world-wide collection of multi-drug resistant pathogens
multi-drug resistant nosocomial infections
clinical microbiology laboratories
microbiological diagnostics
clinical microbiological laboratories
addition
optimization of current diagnostics
molecular StG-knowledge
gram-negative pathogens
critical information
critical appraisal
commercialization opportunities
CE label
improvement of disease surveillance
current paradigm of culture
steps of pre-commercialization
PIs medical microbiology background
previous ERC-funded work
contacts
protection of intellectual property
end users
antibiotic use
respect
decade
antimicrobials
pharmaceutical industry
lack of therapy options
market research
decision-making
simultaneous pursuit of exploratory
prevention
therapies
need
phase
development
proposal
door
assessment
licensing
genotyping
technology transfer company Ascenion
spread
overall objective
organisms
project
service
high priority